ClinicalTrials.gg
Active, not recruitingNCT06933446Updated Apr 18, 2025

Effect of Myofascial Release on Post-Exercise Recovery in Water Polo Athletes

An interventional study of Myofascial Release and Classic Massage in Fatigue, sponsored by Luis Gustavo Lizi Jorge. Active, not recruiting at 1 site in Brazil. Open to male participants aged 16 Years to 25 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-04-18.

Sponsored by Luis Gustavo Lizi Jorge · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Registered 1 year 1 month after the study started (first participant enrolled Feb 2024, registered Mar 2025).

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
16
Allocation
Randomized
Ages
16 Years to 25 Years
Sex
Male
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 57 studies in Fatigue with a site in Brazil — 9 open to participants now, 13 under way, 2 of them phase 3. Fatigue · Brazil.

Planned enrollment
50th of 54
16 · median 40
Started
2024
with 2 others
No phase
44 of 57
5 open now
Primary completion
2026-12
later than 10 of 12 live
Registered
50th of 57
by date

Among the 57 studies in Fatigue with a site in Brazil, this one is the 50th largest by planned enrollment of the 54 interventional ones that give a count, is one of 3 that started in 2024, is one of 44 with no phase, reaches primary completion later than 10 of the 12 other live ones, and was the 50th registered.

Fatigue

2,234 studies on the registry are indexed under Fatigue; 430 are open to participants now.

Browse Fatigue studies →

Open to participants now

9 of the 57 studies in Fatigue with a site in Brazil are open now. Recruiting first, the newest first:

4 more — sign in →

All 9 open studies →

A study can be open while its sites in Brazil have not opened yet or have stopped. Only those recruiting at a site in Brazil →

Who these studies take

Of the 242 Fatigue studies recruiting now, 113 (47%) set no upper age limit and 99 (41%) stop at 75 or younger; 23 take children under 18; 74 take healthy volunteers.

This study: 16 Years to 25 Years · male · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 57 studies in Fatigue with a site in Brazil, or all of them as a file.
02

Study summary

Objective: To assess the acute effect of a myofascial release protocol applied to the adductor muscles of the thigh on functional, biomechanical, and physiological variables. Methods: This study is a randomized, double-blind, two-arm crossover clinical trial that will analyze male water polo athletes aged 16 to 25 years recruited from a sports training center in the city of Bauru. Data related to the following parameters will be collected for the physical evaluation: functional performance, through the jump test; biomechanical, through maximum isometric torque of hip adductors, electromyography of the hip and gluteus medius muscles; and physiological, through the analysis of serum markers of muscle damage and inflammation, and heart rate variability. After the initial evaluation, the participants will be randomly divided into two groups: intervention group and sham group. Then, all participants will perform a game simulation. After the game, the participants will receive the intervention designated for each group. For the intervention group, a manual therapy protocol will be applied, based on myofascial release in the thigh region that presents trigger points. For the Sham group, a manual technique, called classic massage, will be applied, with superficial pressure, used to reach only subcutaneous tissues, without acting on muscles and fascia. This protocol will be repeated at four different times, always after the games. After a washout week, the participants will change groups and the data collection protocol will be applied again.

03

Conditions studied

  • Fatigue

Browse trials for

Keywords

  • fatigue
  • physical exertion
  • post-exercise recovery
04

Who can participate

Ages eligible
16 Years to 25 Years
Sexes eligible
Male
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Male athletes;
  2. Age 16 to 25 years old;
  3. Have at least one year of experience in the sport;
  4. Perform a training load of at least 10 hours per week in the sport;
  5. Participate in at least regional level competitions

Exclusion criteria

Exclusion Criteria:

  1. Have no reports of muscle injury in the thigh in the three months prior to the study,
  2. Joint injuries in the hip, such as femoroacetabular impingement or tendinopathies of the tendons of the hip muscles or trochanteric, iliopectineal or ischial bursitis diagnosed by a clinician;
  3. Do not present a drop in -performance for more than four weeks that could characterize the occurrence of non-functional overreaching or signs of overtraining syndrome
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
16 participants (estimated)

Study arms

  • Active comparator
    Myofascial Release

    Other: Classic Massage

  • Placebo comparator
    Classic Massage

    Other: Myofascial Release

Interventions

  • OtherMyofascial Release

    A myofascial release protocol, applied to the thigh muscles in post-effort recovery in water polo athletes.

  • OtherClassic Massage

    Massagem clássica, com pressão superficial, utilizada para atingir apenas tecidos subcutâneos, sem que haja ação sobre músculos e fáscias

06

What researchers measure

Primary outcomes

  1. Maximum Vertical Jump Test

    Time frame: From enrollment to the end of treatment at 2 weeks

  2. Maximum Voluntary Isometric Torque of the Hip Adductors

    Time frame: From enrollment to the end of treatment at 2 weeks

  3. Electromyography of Adductors, Gluteus Medius and Transversus Abdominis

    Time frame: From enrollment to the end of treatment at 2 weeks

  4. Collection of Serum Markers

    The markers: creatine kinase (CK; Units of Measure= U/L), lactate dehydrogenase (LDH; Units of Measure= UI/L), myoglobin (Myo; Units of Measure= ng/mL), erythrocyte sedimentation rate (ESR; Units of Measure= mm/h), tumor necrosis factor alpha (TNFA; Units of Measure= Å) will be considered for analysis of muscle damage markers and will be determined through specific kits and following the manufacturer's instructions.

    Time frame: From enrollment to the end of treatment at 2 weeks

  5. Heart Rate Variability

    Heart rate variability (HRV) will be collected, at rest, through a non-invasive method used to measure cardiac autonomic control, to assess the autonomic nervous system (ANS), and the RR interval will be recorded by a portable heart rate monitor.

    Time frame: From enrollment to the end of treatment at 2 weeks

Secondary outcomes

  1. Effort Control Variables: Subjective Perception of Exertion and Lactate Threshold

    To estimate the intensity of the exercise, the method proposed by Foster (1998) will be used, which suggests multiplying the subjective perception of exertion (RPE) of the session by the total duration of the training session (sRPE), with the results expressed in arbitrary units (u.a.). To quantify performance during the game, lactate will be collected at the end of each quarter of the game, through blood collections from the earlobe (25 μL) to analyze the peak lactate concentration (\[La-\]peak) of the effort.

    Time frame: From enrollment to the end of treatment at 2 weeks

07

Study locations

1 site
  • Universidade do Sagrado Coração
    Bauru, São Paulo 17011-160, Brazil
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Feb 2024 (actual). Primary completion is estimated for Dec 2026, 34 months after the start.

Of 937 non-industry interventional studies with no phase under Fatigue, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 27. This study's planned 34 months is above that.

Counting every sponsor, half of 990 studies reached it within 12 months; a quarter within 5 and three quarters within 27.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 26, 2025
First posted
Apr 18, 2025
StartActual
Feb 1, 2024
Primary completionEst.
Dec 1, 2026
CompletionEst.
Dec 1, 2026
Last update
Apr 18, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 18, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06933446
Lead sponsor
Luis Gustavo Lizi Jorge
Responsible party
Luis Gustavo Lizi Jorge (Physiotherapist, Universidade do Sagrado Coração) — Sponsor-investigator
First posted
Apr 18, 2025
Start date
Feb 1, 2024
Primary completion
Dec 1, 2026 (estimated)
Completion
Dec 1, 2026 (estimated)
Last update
Apr 18, 2025

Study contacts

Rebeca Gasparoto Carmezin, Acadêmica em Fisioterapia
principal investigator · Universidade do Sagrado Coração

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Apr 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion